Skip to content

Clinical trials

Phase 1 Peripheral Arterial Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 1 Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20044
20052
20062
20074
20081
20092
20121
20133
20142
20157
20163
20177
20181
20192
20203
20212
20223
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status9
Terminated4
Withdrawn3
Recruiting2
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genovate Biotechnology Co., Ltd.,5
National Heart, Lung, and Blood Institute (NHLBI)4
Proteon Therapeutics3
Ajou University School of Medicine2
Alucent Biomedical2
Lee's Pharmaceutical Limited2
Milton S. Hershey Medical Center2
Pluristem Ltd.2
Shanghai 10th People's Hospital2
Arkansas Heart Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease60
Intermittent Claudication17
Peripheral Vascular Diseases11
Chronic Limb-Threatening Ischemia8
Atherosclerosis7
Cardiovascular Diseases7
Diabetes Mellitus3
Inflammation3
Vascular Diseases3
Acute Coronary Syndrome2

Trials

Showing 76 to 60 of 60. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.